TTF1 and non-small cell lung carcinoma: Firstly, we conducted a multicenter retrospective analysis to explore the prognostic value of TTF-1 expression in patients with advanced non-squamous NSCLC receiving first-line immunotherapy or chemo-immunotherapy, and secondly, we performed a systematic literature review and meta-analysis to integrate our findings within the broader scientific context.